MINIMS PREDNISOLONE Single-use eye drops Ref.[7047] Active ingredients: Prednisolone

Source: Medicines & Healthcare Products Regulatory Agency (GB)  Revision Year: 2017  Publisher: Bausch & Lomb UK Limited, Bausch & Lomb House, 106 London Road, Kingston-Upon-Thames, Surrey, UK, KT2 6TN

Product name and form

Minims Prednisolone Sodium Phosphate.

Pharmaceutical Form

Sterile single-use eye drop.

Qualitative and quantitative composition

Clear, colourless, sterile eye drops containing Prednisolone Sodium Phosphate Ph. Eur. 0.5% w/v.

For the full list of excipients, see section 6.1.

Active Ingredient Description
Prednisolone

Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems.

List of Excipients

Disodium edetate
Sodium dihydrogen phosphate
Sodium chloride
Sodium hydroxide for pH adjustment
Purified water

Pack sizes and marketing

A sealed conical shaped polypropylene container fitted with a twist and pull off cap. Each Minims unit is overwrapped in an individual polypropylene/paper pouch. Each container holds approximately 0.5ml of solution.

Marketing authorization holder

Bausch & Lomb UK Limited, Bausch & Lomb House, 106 London Road, Kingston-Upon-Thames, Surrey, UK, KT2 6TN

Marketing authorization dates and numbers

PL 03468/0079

Date of first authorisation: 11th March 1981

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.